Kurtz Ronald M MD's Form 4 filing
RxSight, Inc. (RXST) · filed Aug 5, 2021
- Accession no.
- 0000899243-21-031814
- Filed
- Aug 5, 2021
- Trade date
- Aug 3-5, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $2.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kurtz Ronald M MDCIK 0001295469 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +125,000 | $16.00 | +$2,000,000 | 125,000 | Direct | |
| Aug 5, 2021 | Common Stock | PPurchaseAcquired | +3,638 | $13.85F2 | +$50,386.3 | 804,610 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 3,638 shares purchased in the price range of $13.50 to $14.00 by Cricklewood LP. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
President & Chief Executive Officer